Fundamental dimension Equity attribute | BEGILeader $0.00010.00% Cap $297.9KP/E -0.5x QuantScore27/100 | BFCHPeer $0.00020.00% Cap $138.7KP/E -1.6x QuantScore25/100 | CNERPeer $0.0040.00% Cap $29.37MP/E -6.1x QuantScore25/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
52/100 |
34/100 |
63/100 |
Valuation Multiples, PEG & DCF upside | 33/100 | 33/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 23/100 | 33/100 | 38/100 |
Growth Revenue / earnings growth & margins | 0/100 | 0/100 | 0/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -0.5x | -1.6x | -6.1x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | -4.5x | -2.3x | -6.6x |
Price / Sales | — | 9.3x | 113.4x |
Price / Free Cash Flow | 1.5x | — | 146.4x |
PEG ratio | -0.00 | 0.01 | -0.06 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | 3 / 9 | 5 / 9 |
Altman Z-Score | -59.56 (Distress) | -8.40 (Distress) | -1394.81 (Distress) |
Total debt / equity | -0.46 | 0.41 | 0.00 |
Quick ratio | 0.0x | 1.9x | 0.0x |
Interest coverage | -2.9x | -46.1x | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | — | -100.0% | — |
Net income growth YoY | -44.7% | -124.9% | -130.9% |
Gross margin (TTM) | 0.0% | -119.9% | 0.0% |
Operating margin (FY) | — | — | — |
FCF margin (FY) | — | — | — |
5. Trailing price performancePrice change over period |
1M return | +9900.0% | 0.0% | 0.0% |
3M return | +0.0% | -33.3% | -42.9% |
6M return | -66.7% | -71.4% | -55.6% |
Year to date | -50.0% | -71.4% | -66.7% |
1Y return | -50.0% | -85.7% | -71.4% |
3Y return | -80.0% | -97.6% | -89.6% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-0.0011 -1242.8% premium | $0.00 -99.6% premium | $-0.0001 -101.3% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |